期刊文献+

动脉粥样硬化大鼠B族Ⅰ型清道夫受体与肾素-血管紧张素系统的表达变化 被引量:1

Study of the Expression of Scavenger Receptor Class B TypeⅠ and Renin Angiotensin System in Atherosclerotic Rats
下载PDF
导出
摘要 目的研究动脉粥样硬化大鼠主动脉B族Ⅰ型清道夫受体、血管紧张素Ⅱ1型受体和2型受体表达、血管紧张素Ⅱ水平的变化及其相互作用,探讨动脉粥样硬化的发生机制。方法将18只大鼠随机分为对照组和动脉粥样硬化组,通过高脂喂养12周、主动脉内皮损伤和维生素D3肌肉注射建立大鼠主动脉粥样硬化模型。HE染色和M asson染色观察主动脉管壁结构和粥样硬化斑块的形成情况,放射免疫法检测血管紧张素Ⅱ的水平,免疫组织化学、W estern B lot检测B族Ⅰ型清道夫受体、血管紧张素Ⅱ1型受体和2型受体的蛋白表达,实时定量逆转录聚合酶链反应检测B族Ⅰ型清道夫受体、血管紧张素Ⅱ1型受体和2型受体的mRNA表达,B族Ⅰ型清道夫受体与血管紧张素Ⅱ、血管紧张素Ⅱ1型受体和2型受体的相关性分析用直线相关分析法。结果HE染色和M asson染色结果发现动脉粥样硬化组大鼠主动脉内粥样硬化斑块形成。动脉粥样硬化组大鼠主动脉血管紧张素Ⅱ水平较对照组明显升高(210.80±31.56 ng/L比121.26±25.32 ng/L,P<0.01)。与对照组比较,动脉粥样硬化组主动脉B族Ⅰ型清道夫受体(0.83±0.19比0.16±0.03)、血管紧张素Ⅱ1型受体(1.02±0.12比0.48±0.11)和2型受体(0.97±0.24比0.13±0.03)的蛋白表达明显升高(均P<0.01),且均主要存在于胞膜和胞浆中。动脉粥样硬化组主动脉B族Ⅰ型清道夫受体(0.76±0.17比0.16±0.04)、血管紧张素Ⅱ1型受体(0.83±0.20比0.33±0.08)和2型受体(0.78±0.13比0.12±0.03)的mRNA表达较对照组明显升高(均P<0.01)。动脉粥样硬化组的B族Ⅰ型清道夫受体蛋白表达与血管紧张素Ⅱ水平及血管紧张素Ⅱ1型受体表达呈显著正相关(r=0.717和r=0.711)。结论动脉粥样硬化大鼠主动脉B族Ⅰ型清道夫受体、血管紧张素Ⅱ1型受体和2型受体表达升高,且B族Ⅰ型清道夫受体表达的增高与血管紧张素Ⅱ产生增加和血管紧张素Ⅱ1型受体激活有关。 Aim To eluciadate the genesis of atherosclerosis by investigating the level of angiotensinⅡ(AngⅡ),the expression of scavenger receptor class B type Ⅰ(SR-BⅠ),angiotensinⅡ receptors type 1(AT1),type 2(AT2) and the relationships among them. Methods Eighteen rats were randomly divided into two groups as control group and atherosclerosis group.Atherosclerosis group were given high cholesterol feeds,vitamin D3 and aorta balloon injury.At the end of 12 weeks,HE and Masson stain were used to detect the structure of aorta wall and atherosclerotic plaque.The concentration of AngⅡ was detected by the method of radio-immunity.The protein expression of SR-BⅠ,AT1 and AT2 were investigated by Western Blot and immunohistochemistry,while their mRNA expression were measured by real time reverse transcription polymerse chain reaction(RT-PCR).The correlation between variances were analyzed by linear regression analysis. Results In atherosclerosis group,some endothelial cells were lost and the intima thicked.The smooth muscle cell(SMC) proliferated and lined up in disorder.The smooth muscles in the media were atrophic slightly.The structures and arrangements of elastic fibers were in disorder and the fibrous tissues proliferated.There were some hyperplasy in the aortic wall and formed atherosclerotic plaques contained with hyperplastic fibers.All of these were observed by HE and Masson stain.The level of AngⅡ in atherosclerosis group was higher than that in control group(210.80±31.56 ng/L vs 121.26 ± 25.32 ng/L,P〈0.01).Compared with control group,the protein expression of SR-BⅠ,AT1 and AT2 increased significantly in atherosclerosis group(0.83±0.19 vs 0.16±0.03,P〈0.01;1.02±0.12 vs 0.48±0.11,P〈0.01;0.97±0.24 vs 0.13±0.03,P〈0.01),and expressed mainly in cell membrane and cytoplasma.The aorta mRNA expression of SR-BⅠ,AT1 and AT2 increased significantly in atherosclerosis group than that in control group(0.76±0.17 vs 0.16±0.04,P〈0.01;0.83±0.20 vs 0.33±0.08,P〈0.01;0.78±0.13 vs 0.12±0.03,P〈0.01).The protein expression of SR-BⅠ was directly related to the level of AngⅡ and the expression of AT1(r=0.717,P〈0.05 and r=0.711,P〈0.05). Conclusion The expression of aortic SR-BⅠ,AT1 and AT2 increase significantly in atherosclerotic rats,furthermore the increased expression of SR-BⅠ is related to the elevation of AngⅡ and activation of AT1.
出处 《中国动脉硬化杂志》 CAS CSCD 北大核心 2009年第11期897-901,共5页 Chinese Journal of Arteriosclerosis
基金 青岛市科学技术局资助项目(02-2-kj-yn-25)
关键词 动脉粥样硬化 B族Ⅰ型清道夫受体 血管紧张素Ⅱ1型受体 血管紧张素Ⅱ2型受体 Atherosclerosis Scavenger Receptor Class B TypeⅠ AngiotensinⅡ Type 1 Receptor AngiotensinⅡ Type 2 Receptor
  • 相关文献

参考文献10

  • 1李永红,葛志明,王其新,冯进波,蔡尚郎,安毅,董果雄,张运.高脂血症患者血浆血管紧张素Ⅱ水平与其血小板1型受体表达的相关性[J].中国动脉硬化杂志,2007,15(3):169-172. 被引量:5
  • 2郭延松,杨军珂,吴宗贵.鼠动脉粥样硬化模型的建立[J].中国动脉硬化杂志,2003,11(1):84-86. 被引量:25
  • 3Nakagawa-Toyama Y, Hirano K, Tsujii K, et al. Human scavenger receptor class B type Ⅰ is expressed with cell-specific fashion in both initial and terminal site of reverse cholesterol transport [ J ]. Atherosderosis, 2005, 183 ( 1 ) : 75-83.
  • 4Yamamoto Y, Watari Y, Brydun A, et al. Role of the angiotensin Ⅱ type 2 receptor in arterial remodeling after wire injury in mice [ J ]. Hypertens Res, 2008, 31 (6): 1 241-249.
  • 5Hayashi K, Miyamoto A, Berisha B, et al. Regulation of angiotensin Ⅱ production and angiotensin receptors in mierovascular endothelial cells from bovine corpus luteum [ J ]. Biol Reprod, 2000, 62 ( 1 ) : 162-167.
  • 6lwai M, Chen R, Li Z, et al. Deletion of angiotensin Ⅱ type 2 receptor exaggerated atherceclerosis in apolipoprotein E-null mice [ J ]. Circulation, 2005, 112 (11): 1 636~43.
  • 7Wolf G, Wenzel U, Jablonski K, et al. Angiotensin Ⅱ down-regulates the SR-B Ⅰ HDL receptor in proximal tubular cells [ J ]. Nephrol Dial Transplant, 2005, 20 (6) : 1 222-227.
  • 8Pilon A, Martin G, Buhel-Bfienne S, et al. Regulation of the scavenger receptor B Ⅰ and the LDL receptor by activators of aldosterone production, angiotensln Ⅱ and PMA, in the human NCI-H295R adrenocortical cell line [J]. Biochim Biophys Acta, 2003, 1631 (3): 218-228.
  • 9Yu X, Murao K, Imachi H, et al. Regulation of scavenger receptor class B Ⅰ gene expression by angiotensin Ⅱ in vascular endothelial cells [ J ]. Hypertension, 2007, 49 (6): 1 378-384.
  • 10White CR, Datta G, Zhang Z, et al. HDL therapy for cardiovascular diseases : the road to HDL mimetics [ J ]. Curr Atheroscler Rep, 2008, 10 (5) : 405-412.

二级参考文献34

  • 1杨小毅,杨永宗,谭健苗,袁中华,万载阳.一种纯系小鼠动脉粥样硬化病理模型的建立[J].中国动脉硬化杂志,1996,4(1):54-57. 被引量:27
  • 2[1]Wissler RW, Eilert ML, Schroeder MA, Cohen L. Production of lipormatous and atheromatous arterial lesions in the albino rat. Arch Pathol, 1954, 57: 333
  • 3[2]Patek PR, Bernick S, Ershoff BH, Wells A. Induction of atherosclerosis by cholesterol feeding in the hypophysectomized rat. Am J Pathol, 1963, 42: 137
  • 4[3]Fleckenstein KN, Kehel L, Bouayadi FE, Fdhil H, Amarti A, Saidi A, et al. New model of atherosclerosis in insulin resistant sand rats: hypercholesterolemia combined with D2 vitamin. Atherosclerosis, 2000, 150: 55-61
  • 5[4]Wilgram GF. Dietary methed for induction of atherosclerosis,coronary occlusion and myocardial infarcts in rats. Proc Soc Exp Biol Med, 1958, 99: 496
  • 6[5]Jellinek H, Harsing J, Fuzcesi SZ. A new model for arteriosclerosis, an electron microscopy study of the lesions induced by i.v. administered fat. Atherosclerosis, 1982, 43: 7-18
  • 7[6]Joen RS, Ching HW, Yi CC, Hsiao G, Lin CH. Mechanisms in the inhibition of neointimal hyperplasis with triflavin in a rat model of balloon angioplasty. J Lab Clin Med, 2001, 13 (4): 270-277
  • 8[7]Fishman JA, Graeme BR, Morris JK, Lin K. Enfothelial regrneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest, 1975, 32: 339-351
  • 9[9]Rekhter MD, Hicks GW, Brammer DW, Work CW, Kim JS, Gordon D, et al. Minimal model that mimics atherosclerotic plaque rupture. Circ Res, 1998, 83: 705-713
  • 10[10]Abela GS, Picon PD, Friedl SE, Gebara OC, Miyamoto A, Federman M, et al. Triggering of plaque disruption and arterial thrombosis in an atherosclerotic rabbit model. Circulation, 1995, 91: 776-784

共引文献28

同被引文献35

  • 1Gordon SM,Deng J,Lu LJ. Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography[J].{H}Journal of Proteome Research,2010,(10):5239-5249.
  • 2Shil AB. Termination of atherothrombosis intervention in metabolic syndrome with low high-density lipoprotein cholesterol and high triglycerides:impact on global health study and decision to use extended-release niacin in elderly[J].{H}Journal of the American Geriatrics Society,2011,(12):2397-2398.
  • 3Moore RE,Navab M,Millar JS. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation[J].{H}CIRCULATION RESEARCH,2005,(08):763-771.
  • 4Adorni MP,Zimetti F,Billheimer JT. The roles of different pathways in the release of cholesterol from macrophages[J].{H}Journal of Lipid Research,2007,(11):2453-2462.
  • 5Navab M,Hama SY,Cooke CJ. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein:step 1[J].{H}Journal of Lipid Research,2000,(09):1481-1494.
  • 6Navab M,Hama SY,Anantharamaiah GM. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein:steps 2 and 3[J].{H}Journal of Lipid Research,2000,(09):1495-1508.
  • 7Suzuki M,Pritchard DK,Becker L. High-density lipoprotein suppresses the type I interferon response,a family of potent antiviral immunoregulators,in macrophages challenged with lipopolysaccharide[J].{H}CIRCULATION,2010,(19):1919-1927.
  • 8Mineo C,Deguchi H,Griffin JH. Endothelial and antithrombotic actions of HDL[J].{H}CIRCULATION RESEARCH,2006,(11):1352-1364.
  • 9Hedrick CC,Thorpe SR,Fu MX. Glycation impairs high-density lipoprotein function[J].{H}DIABETOLOGIA,2000,(03):312-320.
  • 10Shao B,Pennathur S,Pagani I. Modifying apolipoprotein A-I by malondialdehyde,but not by anarray of other reactive carbonyls,blocks cholesterol efflux by the ABCA1 pathway[J].{H}Journal of Biological Chemistry,2010,(24):18473-18484.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部